Prognostic impact of Cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study

Lung Cancer

Volumn 27, Issue 1, 2000, Pages 19-26

  Fujise, Naoki ^a   Nanashima, Atsushi ^a   Taniguchi, Yoshitaka ^a   Matsuo, Satoshi ^a   Hatano, Kazuhiko ^a   Matsumoto, Yoshihiro ^a   Tagawa, Yutaka ^a   Ayabe, Hiroyoshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cathepsin B; Matrix metalloproteinase 9; Pulmonary adenocarcinoma

Indexed keywords

CATHEPSIN B; METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT DISEASE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CATHEPSIN B; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033991266     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(99)00088-4     Document Type: Article

References (26)

1. Lah T.H., Buck M.R., Honn K.V. Degradation of lamin by human tumor Cathepsin B. Clin. Exp. Metastasis. 7:1989;461-468.
2. Liotta L.A. Tumor invasion and metastasis - role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res. 46:1986;1-7.
3. Liotta L.A., Steeg P.S., Stetler-Stevson W. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64(2):1991;327-336.
4. Sloane B.F., Honn K.V., Sadler J.G. et al. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res. 42:1982;980-986.
5. Rozihn J., Robinson D., Sloan B.F. et al. Properties of a plasma membrane-associated Cathepsin B-like cysteine proteinase in metastatic B16 melanoma varriant. Cancer Res. 47:1987;6620-6628.
6. Sloan B.F., Rozhin J., Johnson K. et al. Cathepsin B: association with plasma membrane in metastatic tumors. Proc. Natl. Acad. Sci. USA. 83:1986;2483-2487.
7. Rozhin J., Gomez A.P., Sloane B.F. et al. Cathpsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulation isolated from murine tumors. Cancer Res. 50:1990;6278-6284.
8. Watanabe M., Higashi T., Hashimoto M. et al. Elevation of tissue cathepsin band L activities in gastric cancer. Hepatogastro. Enterol. 34:1987;120-122.
9. Sheahan K., Shuja S., Murnane M.J. et al. Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer. Res. 49:1989;3809-3814.
10. Poole A.R., Tiltman K.J., Recklies A.D. et al. Differences in secretion of the proteinase Cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature. 273:1978;545-547.
11. Hirano T., Manabe T., Takeuchi S. Serum Cathepsin B levels and urinary excretion of Cathepsin B in the cancer patients with remote metastasis. Cancer Letts. 70(1-2):1993;41-44.
12. Higashiyama M., Doi O. The prognostic implications of the Cathepsin B expression in plumonary adenocarcinomas - an immnohistochemical study. Jpn. J. Cancer. Clin. 37:1991;1151-1157.
13. Ozeki Y., Takishima K., Takagi K. et al. Immunohistochemical analysis of Cathepsin B expression in human lung adenocarcinoma - the role of in cancer progression. Jpn. J. Cancer Res. 84:1993;972-975.
14. Zucker S. MMP-9 is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 53(1):1993;140-146.
15. David L., Nesland J.M. Expression of laminin, collagen, fibronectin, and type collgenase in gastric carcinoma. Cancer. 73:1994;518-527.
16. Brown P.D., Bloxidge R.E., Stuart N.S. Association between expression of activated 72 kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J. Natl. Cancer Inst. 85:1993;574-578.
17. Ogata Y., Paratta M., Nagase H. et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type is indused in rabbit articular chondrocytes by cotreatment with interleukin 1 and a protein kinase C activator. Exp. Cell. Res. 201:1992;245-249.
18. Sukoh N., Abe S., Nakajima I. et al. Immnohistochemical study of Cathepsin B-prognostic significance in human lung cancer. Cancer. 74:1994;46-51.
19. Higashiyama M., Doi O., Kodama K. et al. Cathepsin B expression in tumor cells and laminin distribution in pulmonary adenocarcinoma. J. Clin. Pathol. 46:1993;18-22.
20. Terranova V.P., Martin G.R., Kleinman H. et al. Regulation of cell attachment and cell number by fibronectin and laminin. J. Cell. Physiol. 127:1986;473-479.
21. Inada K., Shimokawa K., Ikeda T. et al. Development of liver metastasis in colorectal carcinoma. Acta Pathol. Jpn. 41:1991;240-245.
22. Kodate M., Kasai T., Hashimoto H. et al. Expression of matrix metalloproteinase(gelatinase) in T1 adenocarcinoma of the lung. Pathol. Int. 47(7):1997;461-469.
23. Ogata Y., Morodomi T., Shiromizu K. et al. Matrix metalloproteinase 9 (92 kDa gelatinase/type collagenase) is implicated in liver metastasis in colorectal cancers. Nippon Geka Gakkai Zasshi. 94(11):1993;1227.
24. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remolding. Trends Genet. 6:1990;121-125.
25. Gonzalez-Alvila G., Iturria C., Vadillo F. et al. 72-kd(MMP-2) and 92 kd(MMP-9) type collagenase production and activity in different histologic types of lung cancer cells. Pathobiology. 66(1):1998;5-16.
26. Mori M., Kohli A., Baker S.P. et al. Laminin and Cathepsin B as prognostic factors in stage non-small cell lung cancer: are they useful? Mod. Pathol. 10(6):1997;572-577.